Saxenda Cost in Ohio (2026): Prices, Insurance, and Savings Options

What Saxenda Costs at Ohio Pharmacies in 2026

The manufacturer list price for Saxenda set by Novo Nordisk is $1,349 per month, and Ohio retail pharmacies generally match this figure for cash-paying patients. A single Saxenda pen contains 18 mg of liraglutide; at the maintenance dose of 3 mg daily, each pen lasts six days, meaning patients need five pens per 30-day supply.

Pricing varies modestly by pharmacy. Large chains like CVS, Walgreens, and Kroger (which operates extensively across Ohio) tend to price within $20 of the list price. Independent pharmacies sometimes negotiate slightly different wholesale rates, but savings rarely exceed 3-5% off list.

The annual cost without any discount or insurance coverage reaches approximately $16,188. That figure puts Saxenda out of reach for many Ohioans, particularly given the state's median household income of roughly $61,000. The SCALE Obesity and Prediabetes trial (N=3,731) demonstrated that liraglutide 3 mg produced 8.0% mean body weight loss versus 2.6% with placebo at 56 weeks, establishing the clinical efficacy that justifies exploring every available cost-reduction strategy [1].

Price-comparison tools like GoodRx and RxSaver sometimes list Ohio-specific discount prices between $1,100 and $1,300 per month, though availability of these coupons fluctuates. Always confirm the final price at the pharmacy counter before filling.

Ohio Medicaid and Saxenda Coverage

Ohio Medicaid does not cover Saxenda for chronic weight management. The Ohio Department of Medicaid formulary lists liraglutide coverage only for type 2 diabetes at the 1.8 mg dose (marketed as Victoza), not at the 3 mg weight-management dose.

This gap affects a significant population. Over 3 million Ohioans are enrolled in Medicaid managed care plans, and Ohio's adult obesity rate stands at approximately 36.4%, according to CDC data on obesity prevalence [2]. The disconnect between clinical need and formulary coverage remains a barrier.

Ohio Medicaid managed care organizations (MCOs) such as CareSource, Molina, Buckeye Health Plan, and UnitedHealthcare Community Plan all follow the state formulary on this restriction. Individual appeals for medical necessity are possible but rarely successful for Saxenda specifically, since the MCOs defer to the state's coverage determination.

Patients on Ohio Medicaid seeking GLP-1 receptor agonist therapy for weight loss may want to discuss alternative medications with their prescriber. Some newer agents in the GLP-1 class have different coverage pathways, though none are guaranteed.

Commercial Insurance Coverage in Ohio

Commercial insurance plans in Ohio offer inconsistent coverage for Saxenda. Some employer-sponsored plans and marketplace plans include it on their formularies; many do not. Plans that do cover Saxenda almost universally require prior authorization demonstrating medical necessity [3].

Typical prior authorization criteria include:

• BMI of 30 or greater, or BMI of 27 or greater with at least one weight-related condition (hypertension, type 2 diabetes, dyslipidemia)
• Documentation of a failed structured diet and exercise program lasting at least 3-6 months
• No concurrent use of other GLP-1 receptor agonists

When approved, copays under commercial plans range from $30 to $150 per month depending on formulary tier. Specialty tier placement (Tier 4 or 5) pushes copays higher. Some Ohio-based plans, including those offered by Medical Mutual of Ohio and SummaCare, have placed Saxenda on non-preferred specialty tiers, meaning patients pay coinsurance (typically 25-40%) rather than a flat copay.

Dr. Caroline Apovian, a leading obesity medicine specialist, has stated: "The biggest barrier to anti-obesity medication use is not clinical evidence. It is insurance coverage and out-of-pocket cost." This observation holds particularly true in Ohio's mixed coverage environment.

Ohio's large self-insured employers (those with 500+ employees who fund their own health plans) have the flexibility to add or remove Saxenda coverage. Patients working for self-insured companies should check directly with their benefits administrator, as these plans are not bound by state insurance mandates.

The Novo Nordisk Savings Card in Ohio

Novo Nordisk offers a manufacturer savings card for Saxenda that can reduce out-of-pocket costs for commercially insured patients. The program's current terms allow eligible patients to pay as little as $25 per 30-day fill, with Novo Nordisk covering up to a defined maximum per month.

Eligibility requirements are straightforward. Patients must have commercial insurance (not government-funded coverage like Medicaid, Medicare, or Tricare), a valid prescription, and U.S. residency. The card is accepted at most Ohio pharmacies, including major chains.

Key limitations apply. The savings card has an annual maximum benefit, typically capped at several thousand dollars per calendar year. Once the cap is reached, patients revert to their plan's standard cost-sharing. The card also cannot be combined with other manufacturer rebates or certain pharmacy discount programs.

For uninsured patients, Novo Nordisk's patient assistance program (PAP) may provide Saxenda at no cost to qualifying individuals. Income thresholds generally fall at or below 400% of the federal poverty level. Application requires documentation of income, a prescription, and proof of lack of coverage. Processing takes 4-6 weeks in most cases.

Ohio patients can verify savings card eligibility and apply through the Novo Nordisk patient access website or by calling the number on the Saxenda prescribing information page [4].

Compounded Liraglutide 3 mg in Ohio

Compounded liraglutide 3 mg is available in Ohio through licensed 503A compounding pharmacies. These pharmacies prepare customized formulations based on individual prescriptions, operating under Section 503A of the Federal Food, Drug, and Cosmetic Act.

Ohio's State Board of Pharmacy regulates compounding pharmacies within the state. A 503A pharmacy must compound in response to a valid, patient-specific prescription and cannot produce medications in bulk for general distribution (that falls under 503B outsourcing facilities, which are FDA-registered).

Pricing for compounded liraglutide varies significantly by pharmacy. Some 503A pharmacies offer compounded liraglutide at substantially lower prices than brand-name Saxenda, though the exact cost depends on the pharmacy's sourcing of active pharmaceutical ingredient (API) liraglutide, compounding complexity, and markup.

Several considerations apply to compounded versions:

• Compounded medications are not FDA-approved products and do not undergo the same regulatory review as brand-name drugs
• Quality and potency can vary between compounding pharmacies
• The FDA has noted that patients should discuss the risks and benefits of compounded medications with their prescriber [5]
• Not all prescribers are willing to write prescriptions for compounded GLP-1 receptor agonists

The American Association of Clinical Endocrinology (AACE) has recommended that "patients using compounded peptides should be monitored with the same rigor as those on FDA-approved formulations, including regular assessment of injection-site reactions and glycemic parameters" [6]. Ohio prescribers who do write for compounded liraglutide should follow this guidance.

Patients considering compounded liraglutide in Ohio should verify the pharmacy's licensure through the Ohio Board of Pharmacy and confirm the pharmacy's compliance history.

Telehealth Prescribing of Saxenda in Ohio

Ohio permits telehealth prescribing of Saxenda statewide. The Ohio State Medical Board allows physicians and advanced practice providers to prescribe controlled and non-controlled medications via telehealth after conducting an appropriate evaluation, which may be audiovisual.

Saxenda is not a controlled substance, which simplifies the telehealth prescribing pathway. Providers do not need a separate DEA telehealth registration, and no in-person visit is required before initiating treatment.

Several national telehealth platforms serve Ohio patients for weight management, including services that specialize in GLP-1 receptor agonist prescribing. These platforms typically charge a consultation fee ($50-$200 for initial visits) separate from the medication cost. Some bundle follow-up visits into a monthly subscription.

The SCALE trial protocol required monthly check-ins with patients, including assessment of weight trajectory, side effects, and dose titration compliance [1]. Telehealth makes this monitoring schedule more accessible for patients in rural Ohio counties, where obesity medicine specialists are scarce. Only 14 of Ohio's 88 counties have board-certified obesity medicine physicians.

Ohio-based health systems including Cleveland Clinic, Ohio State University Wexner Medical Center, and UC Health also offer telehealth weight management programs, sometimes with better insurance integration than standalone telehealth companies.

Strategies to Lower Saxenda Costs in Ohio

Multiple approaches can reduce what Ohio patients pay for Saxenda. No single strategy works for everyone, but combining options often produces the best result.

Savings card plus commercial insurance. The most effective combination for employed, commercially insured patients. If the plan covers Saxenda, the savings card can reduce the remaining copay to $25 per month.

Pharmacy price shopping. Prices differ across Ohio pharmacies by $50-$200 per fill. Costco pharmacies (membership not required for pharmacy services in Ohio) and some Kroger locations tend toward lower pricing. Call at least three pharmacies before filling.

Patient assistance programs. Uninsured patients earning below 400% FPL should apply to the Novo Nordisk PAP before paying cash. The program provides Saxenda at no cost for qualifying patients.

Mail-order pharmacies. Some PBMs offer 90-day fills at reduced per-unit costs through mail-order. This works best when combined with insurance coverage.

Clinical trials. ClinicalTrials.gov lists active obesity treatment trials recruiting in Ohio. Participants often receive study medication at no cost, though trial availability changes frequently [7].

Flexible Spending and Health Savings Accounts. Saxenda qualifies as an eligible medical expense under FSA and HSA rules. Paying with pre-tax dollars effectively reduces the cost by the patient's marginal tax rate (22-32% for most Ohio households).

The Endocrine Society's 2024 clinical practice guideline on pharmacological management of obesity recommends that "cost and insurance coverage should be discussed with patients at the time of prescribing, as adherence to anti-obesity medications drops significantly when monthly out-of-pocket costs exceed $50" (Endocrine Society, 2024) [8]. This threshold underscores why cost reduction matters clinically, not just financially.

Saxenda vs. Other Weight-Loss Medications: Ohio Pricing Context

Saxenda's $1,349 monthly cost in Ohio sits in the mid-range of branded anti-obesity medications. For comparison, Wegovy (semaglutide 2.4 mg) lists at approximately $1,349 per month, while Zepbound (tirzepatide) lists at roughly $1,060 per month.

The critical difference is coverage. Some Ohio commercial insurers have added Wegovy or Zepbound to formularies while excluding Saxenda, or vice versa. Ohio Medicaid's exclusion of all three for chronic weight management levels the playing field at the bottom: none are covered.

From an efficacy standpoint, the STEP-1 trial (N=1,961) showed semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo [9]. The SCALE trial showed liraglutide 3 mg produced 8.0% loss at 56 weeks [1]. Both exceed the FDA's 5% threshold for clinically meaningful weight loss, but the magnitude differs.

Ohio patients choosing between these options should weigh three factors: which medications their insurance covers, their tolerance for injection frequency (daily for Saxenda vs. weekly for Wegovy), and their prescriber's clinical judgment about which agent best fits their metabolic profile.

Older generic options like phentermine and topiramate cost $15-$40 per month but carry different side effect profiles and are FDA-approved only for short-term use (phentermine) or off-label (topiramate).

Ohio-Specific Discount and Assistance Programs

Beyond manufacturer programs, several Ohio-specific resources exist for patients struggling with medication costs.

Ohio's Best Rx program, administered through the Ohio Department of Aging, provides prescription drug discount cards to Ohio residents of all ages. The card is free and accepted at most Ohio pharmacies. Discounts on brand-name medications like Saxenda typically range from 10-20%, though the actual discount depends on the pharmacy's contracted rate.

Ohio FreeClinic networks, including those in Cleveland, Columbus, Cincinnati, and Akron, sometimes maintain relationships with pharmaceutical representatives who can provide medication samples. Samples are short-term solutions but can bridge coverage gaps.

Community health centers designated as Federally Qualified Health Centers (FQHCs) in Ohio participate in the 340B Drug Pricing Program, which allows them to purchase outpatient drugs at significantly reduced prices. Patients receiving care at a 340B-eligible site may access Saxenda at lower cost, though 340B pricing is not available at standard retail pharmacies.

Ohio has 54 FQHC organizations operating over 400 service delivery sites statewide, according to the Health Resources and Services Administration [10]. Patients in both urban and rural areas can locate a nearby site through the HRSA Find a Health Center tool.